Woodline Partners LP Forte Biosciences, Inc. Transaction History

Woodline Partners LP

$11 Billion
Q3 2024

Shares

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q4 2021 Feb 14, 2022	SELL	$2.02 - $3.36 $289,068 - $480,826	-143,103 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$2.96 - $36.67 $149,657 - $1.85 Million	-50,560 Reduced 26.11%	143,103 $424,000
Q2 2021 Aug 16, 2021	BUY	$31.5 - $42.5 $105,462 - $142,290	3,348 Added 1.76%	193,663 $6.51 Million
Q1 2021 May 17, 2021	SELL	$25.01 - $40.24 $48,794 - $78,508	-1,951 Reduced 1.01%	190,315 $6.52 Million
Q4 2020 Feb 16, 2021	BUY	$28.66 - $46.79 $5.51 Million - $9 Million	192,266 New	192,266 $7 Million

Others Institutions Holding FBRX

# of Institutions

1

Shares Held

175K

Call Options Held

0

Put Options Held

0

Black Rock Inc. New York, NY

175K
Shares

$977,456
0.0% of portfolio

About Forte Biosciences, Inc.

Ticker FBRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,340,300
Market Cap $114M
Description
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. It is developing FB-102 program that addresses various autoimmune diseases, such as vitiligo and alopecia areata. The company is headquartered in Dallas, Texas.

More about FBRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.